0001628280-26-017230
SEC filingAllogene Therapeutics, Inc. furnished Item 2.02 results of operations and Exhibit 99.1 press release dated March 12, 2026, pursuant to SEC Form 8-K filed on March 12, 2026. The disclosure is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.